🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Secondary Peritoneal Cancers

Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) in Gastric Cancer NCT07313579n/a1 site📍 Kyiv Ukrainian Society of Clinical Oncology · Tests: curative-intent surgery + HIPEC Dual-targeting HER2 and PD-L1 CAR-T for Solid Tumors NCT04684459EARLY Phase 11 site📍 Chengdu Sichuan University · Tests: Dual-targeting HER2 and PD-L1 CAR-T cells INTERACT Stomach-II NCT07133490Phase 23 sites📍 Amsterdam📍 Eindhoven📍 Rotterdam Erasmus Medical Center · Tests: intraperitoneal chemotherapy A Prospective Multicentre Clinical Study of Dynamic Monitoring of Plasma ctDNA Methylation Markers to Predict Recurrence of Colorectal Cancer After Complete Resection of Peritoneal Metastases NCT06903325n/a1 site📍 Shanghai Fudan University · Tests: As an observational study, we did not intervene Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer NCT04107077Phase 21 site📍 Chicago University of Chicago · Tests: Cisplatin, Mitomycin Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001) NCT05579366Phase 1, Phase 266 sites📍 Phoenix📍 Tucson📍 Los Angeles Genmab · Tests: Rina-S, Carboplatin, Bevacizumab, Pembrolizumab, Erythromycin MT027 in Patients With Advanced Peritoneal Malignancies or Abdominal Metastatic Solid Tumors NCT06912152Phase 11 site📍 Hangzhou Zhejiang University · Tests: MT027 CAR-T cells Dual-targeting VEGFR1 and PD-L1 CAR-T for Pleural, Peritoneal, or Leptomeningeal Metastases NCT05477927Phase 11 site📍 Chengdu Sichuan University · Tests: Dual-targeting VEGFR1/PD-L1 CAR-T cells LM-302 and S-1 Plus Intraperitoneal Paclitaxel With or Without Cadonilimab for Claudin 18.2-positive Gastric or Gastroesophageal Junction Adenocarcinoma With Peritoneal Metastasis: a Prospective, Exploratory Study NCT07556640Phase 21 site📍 Shanghai Ruijin Hospital · Tests: LM-302, S-1, paclitaxel, LM-302, Cadonilimab, S-1, paclitaxel Technical Feasibility of Modified Early Post-Operative Intraperitoneal Chemotherapy (mEPIC) NCT05913674Phase 21 site📍 Montreal Ciusss de L'Est de l'Île de Montréal · Tests: Modified early post-operative intraperitoneal chemotherapy (mEPIC) A Phase II Clinical Study to Evaluate the Efficacy and Safety of Technetium [99mtc]-H7ND Injection in the Diagnosis of Peritoneal Metastasis of Gastrointestinal Malignant Tumor. NCT07107633Phase 21 site📍 Shanghai Jiaxing Pharmadax Genesis Pharmaceutical Technology Co.,Ltd. · Tests: Technetium [99mTc]-H7ND injection A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors NCT04657068Phase 1, Phase 288 sites📍 Birmingham📍 Scottsdale📍 Little Rock Artios Pharma Ltd · Tests: ART0380, Gemcitabine, Irinotecan A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer NCT07213804Phase 3265 sites📍 Birmingham📍 Phoenix📍 Burbank Eli Lilly and Company · Tests: Sofetabart Mipitecan, Paclitaxel, Topotecan, Gemcitabine, Pegylated liposomal doxorubicin (PLD) Radical Surgery Versus Non-Surgery in Gastric Cancer Patients With Peritoneal Metastasis After Successful Conversion Therapy NCT07789184Phase 331 sites📍 Beijing📍 Beijing📍 Beijing Hua Huang, MD, PhD · Tests: Radical Gastrectomy with D2 Lymphadenectomy, Standard Systemic Therapy for Advanced Gastric Cancer FAPI-Guided Radiotherapy With Cadonilimab and Standard Chemotherapy for Colorectal Peritoneal Metastasis: A Phase III Randomized Controlled Trial (TORHC-PM02) NCT07815834Phase 31 site📍 Shanghai Fudan University · Tests: Second-Line Chemotherapy, Radiation Therapy, Cadonilimab (AK104) PITCHER (Peritoneal Carcinomatosis Heterogeneity) NCT04714957n/a1 site📍 Lyon Hospices Civils de Lyon · Tests: construction of a database of genetic and epigenetic data on peritoneal carcinomatosis of colorectal or ovarian origin. Tocilizumab Delivered Via Pleural and Peritoneal Catheters in Patients With Advanced Metastatic Cancer NCT06016179Phase 11 site📍 Pittsburgh Allegheny Singer Research Institute (also known as Alleghen… · Tests: Tocilizumab TLR9 Immunotherapy for Peritoneal Carcinomatosis NCT07658196Phase 11 site📍 Providence Brown University · Tests: ACM-CpG Efficacy of Hyperthermic Intraperitoneal Chemotherapy NCT04861558Phase 35 sites📍 Ahmedabad📍 Gothenburg📍 Malmö Uppsala University · Tests: 5Fluorouracil, Irinotecan, Oxaliplatin Intra-tumoral (IT) Injection of vvDD-hIL2-2-RG-1 for Metastatic Gastrointestinal and Peritoneal Tumors NCT07001592Phase 11 site📍 Pittsburgh Allegheny Singer Research Institute (also known as Alleghen… · Tests: vvDD-hIL-2-RG-1 Pressurized Intraperitoneal Aerosolized Nab-Paclitaxel in Combination With Gemcitabine and Cisplatin for the Treatment of Biliary Tract Cancer Patients With Peritoneal Metastases NCT05285358Phase 11 site📍 Duarte City of Hope Medical Center · Tests: Cisplatin, Gemcitabine, Nab-paclitaxel, Quality-of-Life Assessment, Questionnaire Administration Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax NCT05092373Phase 11 site📍 Houston M.D. Anderson Cancer Center · Tests: Atezolizumab, Cabozantinib S-malate, Nab-paclitaxel, Tumor Treating Fields Therapy Clinical Trial on HIPEC With Mitomycin C in Colon Cancer Peritoneal Metastases (GECOP-MMC) NCT05250648Phase 431 sites📍 Elche📍 Almería📍 Badajoz Hospital Universitario de Fuenlabrada · Tests: complete cytoreductive surgery plus HIPEC with Mytomicin C for 90 minutes, complete cytoreductive surgery without HIPEC Integrated Cancer Repository for Cancer Research NCT02012699n/a42 sites📍 Greenwood Village📍 Manchester📍 Daytona Beach University of Nebraska The Role of 18F-FDG&68Ga-FAPI PET/CT in the Assessment of Conversion Therapy Efficacy in Gastric Cancer with Peritoneal Metastasis. NCT06597526n/a1 site📍 Shanghai Ruijin Hospital Torvutatug Samrotecan With or Without Bevacizumab as Maintenance Treatment of Platinum-sensitive Relapsed Epithelial Ovarian Cancer NCT07816666Phase 3124 sites📍 Anchorage📍 Miami📍 Indianapolis AstraZeneca · Tests: Torvutatug samrotecan, Bevacizumab Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial NCT05564377Phase 2484 sites📍 Birmingham📍 Mobile📍 Anchorage National Cancer Institute (NCI) · Tests: Alpelisib, Binimetinib, Biopsy Procedure, Biospecimen Collection, Bone Marrow Aspiration Intraperitoneal Paclitaxel and Systemic Therapy Versus Systemic Therapy Alone in Gastric Cancer Patients With Peritoneal Metastasis NCT07304271Phase 37 sites📍 Verona📍 Amsterdam📍 Gothenburg Magnus Nilsson · Tests: Intraperitoneal Paclitaxel, Standard systemic therapy HS-20089 in Patients With Ovarian Cancer and Endometrial Cancer NCT06014190Phase 228 sites📍 Hefei📍 Beijing📍 Beijing Hansoh BioMedical R&D Company · Tests: HS-20089 Detection of Aneuploidy in Cell Free DNA to Improve the Sensitivity of Diagnostic Peritoneal Lavage in Gastric Cancer NCT06308510n/a1 site📍 Rotterdam Erasmus Medical Center · Tests: collection additional peritoneal lavage fluid
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy